Benefits and Harms of Osteoporosis Medications in Patients With Chronic Kidney Disease

Lisa M. Wilson,Casey M. Rebholz,Ermias Jirru, Marisa Chi Liu,Allen Zhang,Jessica Gayleard,Yue Chu,Karen A. Robinson

Annals of Internal Medicine（2017）

引用 71|浏览5

暂无评分

摘要

This systematic review of 13 trials addresses benefits and harms of osteoporosis medications, including bisphosphonates, teriparatide, raloxifene, and denosumab, for patients with chronic kidney di...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要